Nov 16 (Reuters) - Zhejiang Hisoar Pharmaceutical
Post# of 36519
![](/assets/46931549/no_avatar_available_thumb.jpg)
* SAYS ITS INDUSTRY FUND IS PARTICIPATING IN VACCINE DEVELOPMENT PROJECT WITH PARTNERS INCLUDING GENEREX BIOTECHNOLOGY
* SAYS PARTNERS ALSO INCLUDE CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION
* SAYS THE VACCINE PROJECT IS STILL AT PRE-CLINICAL STAGE Source text in Chinese: https://bit.ly/3lBKucl Further company coverage: (Reporting by Hong Kong newsroom)
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)